AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET

Company Participants

Caroline Corner - Managing Director, Investor Relations

Jim Corbett - Chief Executive Officer

Sean Ekins - Acting Chief Financial Officer

Conference Call Participants

Joshua Jennings - Cowen

Phillip Dantoin - Piper

Brooks O'Neil - Lake Street Capital Markets

Lyanne Harrison - Bank of America

Operator

Good day and thank you for standing by. Welcome to AVITA Medical Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Caroline Corner Please go ahead.

Caroline Corner

Thank you, operator. Welcome to AVITA Medical fourth quarter 2022 earnings call.

Before we begin, let me remind you that this call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which AVITA Medical operates, trends, demand and expectations for its products and technology, its expected financial performance, expenses and position in the market.

These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from any results, performance or achievements expressed or implied by the forward-looking statements.

Please review AVITA Medical’s most recent filings with the SEC, particularly the risk described in AVITA Medical’s annual report on Form 10-K for the year ended December 31, 2022 for additional information. Any forward-looking statements provided during this call, including projections for future performance are based on management’s expectations as of today.

AVITA Medical undertakes no obligation to update these statements, except as required by applicable law. AVITA Medical’s press release for fourth quarter 2022 results is available on its website, www.avitamedical.com under the Investors section and includes additional details about its financial results. AVITA Medical’s website also has the latest SEC filings, which you’re encouraged to review. Recording of today’s call will be available on AVITA Medical’s website by 5:00 PM Pacific Time today.

Joining me on today’s call are Jim Corbett, Chief Executive Officer; and Sean Ekins, Acting Chief Financial Officer.

I'll now turn the call over to Jim for his comments.